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ABSTRACT 21 
Aims 22 
Conducting gaps in lesion sets are a major reason for failure of ablation procedures. Voltage mapping and 23 
pace-capture have been proposed for intraprocedural identification of gaps. We aimed to compare gap size 24 
measured acutely and chronically post-ablation to macroscopic gap size in a porcine model 25 
Methods 26 
Intercaval linear ablation was performed in 8 Göttingen minipigs with a deliberate gap of ~5mm left in 27 
the ablation line. Gap size was measured by interpolating ablation contact force values between ablation 28 
tags and thresholding at a low force cut off of 5g. Bipolar voltage mapping and pace-capture mapping 29 
along the length of the line were performed immediately, and at 2 months, post-ablation. Animals were 30 
euthanized and gap sizes were measured macroscopically.  31 
Results 32 
Voltage thresholds to define scar were determined by ROC analysis as <0.56mV (acutely) and <0.62mV 33 
(chronically). Taking the macroscopic gap size as gold standard, error in gap measurements were 34 
determined for voltage, pace-capture and ablation contact force maps. All modalities overestimated 35 
chronic gap size, by 1.4±2.0mm (ablation contact force map), 5.1±3.4mm (pace-capture) and 9.5±3.8mm 36 
(voltage mapping). Error on ablation contact force map gap measurements were significantly less than for 37 
voltage mapping (P=0.003, Tukey's multiple comparisons test). Chronically, voltage mapping and pace-38 
capture mapping overestimated macroscopic gap size, by 11.9±3.7 and 9.8±3.5mm, respectively. 39 
Conclusions 40 
Bipolar voltage and pace-capture mapping overestimate the size of chronic gap formation in linear ablation 41 
lesions. The most accurate estimation of chronic gap size was achieved by analysis of catheter-42 
myocardium contact force during ablation. 43 
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CONDENSED ABSTRACT 46 
Gaps in ablation sets are a major reason for procedural failure. We compared gap size using pace capture, 47 
voltage and contact force maps to chronic macroscopic gap size in a porcine model. All modalities over 48 
estimated gap size. Error on contact force measurements were significantly less than for voltage mapping.   49 
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WHAT’S NEW? 50 
• This is the first comparison of the accuracy of intra-procedural methods for identifying ablation 51 
lesion gaps at determining eventual gap size.  52 
• Voltage, pace-capture and contact force maps overestimated chronic gap size. 53 
• Contact force maps were most accurate in predicting chronic gap size.   54 
• Conduction velocity within the gap correlated with gap size measured macroscopically and on 55 
contact force maps.  56 
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INTRODUCTION 57 
Radiofrequency ablation forms the cornerstone of invasive management of atrial arrhythmias including 58 
atrial fibrillation (AF). Successful ablation involves delivery of radiofrequency (RF) energy to critical 59 
areas of atrial myocardium resulting in lesions incapable of electrical conduction. Arrhythmia recurrence 60 
post ablation is often attributed to electrically conducting gaps in ablation lesion sets representing failure 61 
of formation of durable, transmural and contiguous lesions (1). Indeed, success rates for AF ablation 62 
remain modest (2) with recurrent AF associated with reconnection of the pulmonary veins to the body of 63 
the left atrium (3). Failure to achieve bidirectional conduction block across ablation lesions increases the 64 
risk of arrhythmia recurrence therefore accurate intra-procedural identification of ablation gaps is likely 65 
to be essential to achieving long term freedom from arrhythmia (4).  66 
Conducting gaps may remain undetected at the index procedure with pulmonary veins appearing 67 
electrically silent due to overlapping local oedema resulting in transitory conduction block (5). Indeed, 68 
increased T2 signal on cardiac MRI, an index of interstitial oedema, has been demonstrated within the 69 
pulmonary vein encirclement in patients with arrhythmia recurrence compared to those without 70 
arrhythmia recurrence (6). Over time, conduction through undetected gaps may resume and potentially 71 
result in arrhythmia recurrence (7). Additional intra-procedural techniques for assessing ablation lesion 72 
integrity have therefore been proposed. Pace-capture mapping was described by Steven et al with loss of 73 
local capture correlating with entrance block in 95% of vein pairs (8), with the inclusion of inexcitability 74 
along the circumferential ablation line as a procedural endpoint resulting in improved clinical outcomes 75 
at 12 months (9). Similarly, analysis of local electrograms at candidate ablation sites may be a useful end-76 
point for assessment of lesion formation during pulmonary vein isolation with higher voltages identifying 77 
sites of electrical connection (10).  78 
Ablation Gap Size 
While the above methods show promise for identification of conducting gaps at the time of ablation, their 79 
ability to adequately predict eventual gap size after chronic remodelling of the ablation scar is not known. 80 
In this study, we therefore compared gap size measured using pace-capture mapping and voltage mapping 81 
to eventual chronic macroscopic gap size in a porcine atrial ablation model. In addition, contact force 82 
maps during ablation were created by analysis of ablation tags. Gap sizes determined on these ablation 83 
contact force maps using a lower contact force threshold of 5g (11) were also compared to eventual chronic 84 
macroscopic gap sizes. 85 
METHODS 86 
Animal model and protocol 87 
The animal protocol complied fully with Danish law governing animal experiments. 8 Göttingen minipigs 88 
(41.2±7.2kg) were pre-sedated with intramuscular azaperone (4mg/kg) and midazolam (0.5mg/kg) before 89 
general anaesthesia was induced with intravenous ketamine (5mg/kg) and midazolam (0.5mg/kg). All 90 
animals were intubated and mechanically ventilated and anaesthesia was maintained with a continuous 91 
intravenous infusion of propofol (3mg/kg/hr) and fentanyl (15ug/kg/hr). All animals underwent 92 
electroanatomic mapping (EAM) and ablation as described below. After ablation, animals were recovered 93 
and returned to the farm for a two-month recovery period. Minipigs were used to ensure minimal growth 94 
during this time period. After 2 months, animals were anaesthetised according to the same protocol and 95 
underwent repeat EAM. Subsequently animals were euthanized, a midline sternotomy was made and the 96 
hearts were removed and perfusion fixed for subsequent analysis.  97 
Electroanatomic mapping and ablation 98 
Two 8Fr right femoral venous sheaths were placed before intravenous injection of 100IU/kg of heparin. 99 
A 6Fr decapolar reference catheter was placed in the coronary sinus (CS) under fluoroscopic guidance. 100 
An 8Fr ablation catheter (Thermocool, SmartTouch, D curve; Biosense Webster) was advanced to the 101 
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right atrium (RA). A right atrial anatomic map was created using the ablation catheter and the Carto 3 102 
electroanatomic mapping system (Biosense Webster). Intercaval linear ablation was performed along the 103 
posterior wall of the RA. This region was chosen as it is easily accessible from the femoral vein, is similar 104 
in morphology to the human atrium and is easily accessed for subsequent dissection. Before commencing 105 
ablation, smooth catheter movement along the proposed line was confirmed. Ablation was performed via 106 
the ablation catheter (3.5mm irrigated tip at 17mls/min) at a temperature of 42°C and a power of 30W 107 
with sufficient contact force to maintain catheter stability (11). Ablation was performed as a continuous 108 
drag with the catheter moved every 30 seconds.  A deliberate ~5mm gap was left in the centre of the 109 
intercaval ablation line created in each animal. High density voltage mapping was performed with the 110 
ablation catheter under CS pacing. 111 
Pace-capture mapping  112 
Pace-capture mapping was performed using bipolar pacing along the length of the intercaval ablation line, 113 
with the output set to twice the capture threshold of healthy myocardium (3mA). Adequate contact was 114 
confirmed with contact force sensing (mean contact force during pacing of 12g) and capture was defined 115 
as consistent capture of the entire chamber (RA) in response to pacing, (Medtronic 5375; 3mA output; 116 
2.0ms pulse width). Sites of pace-capture along the line were marked with Carto tags superimposed onto 117 
the voltage map. Bipolar voltage was measured at each attempted pace-capture site and used to perform 118 
ROC analysis to define voltage thresholds used in subsequent analysis.  119 
Gap Measurement 120 
Voltage. Gap size on voltage maps was measured using the distance measurement tool on the Carto 121 
platform and defined as the largest area of contiguous voltage above the low voltage threshold.  122 
Pace-Capture. Gap size on pace capture maps was determined by measuring the longest length of 123 
contiguous pace-capture points within the linear ablation line using the Carto measurement tool. Ablation 124 
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Contact Force. Contact force maps during ablation were created by interpolating force data from Carto 125 
ablation tags to a maximum of 5mm from each ablation point and thresholding the resulting map at a low 126 
force cut-off of 5g. Gap size was determined by measuring the largest contiguous length of force below 127 
the threshold value. 128 
Gap Conduction Velocity 129 
To determine the average conduction velocity (CV) within the ablation gap, a region of interest was drawn 130 
between ends of the ablation line, and used to extract the interpolated activation times, !, from the Carto 131 
local activation time map (Figure 1). Average CV for the gap region, "̅, was then calculated as: 132 
"̅ = 1&' 1‖∇!*‖+*,-  133 
Where & is the number of elements in the gap region and . is the element index. 134 
Macroscopic analysis 135 
After removal, hearts were suspended in cold normal saline. The aorta and main pulmonary artery were 136 
cannulated and the SVC, IVC and pulmonary veins cross-clamped. Retrograde perfusion fixation of the 137 
heart was performed using 1L of Karnovsky’s fixative (Solmedia Ltd., Shrewsbury, United Kingdom) per 138 
heart. The ablation line and surrounding tissue were removed en bloc and mounted in plastic frames.  Gap 139 
length in the cranial-caudal axis was measured manually on the macroscopic specimens using a ruler.  140 
Statistical Analysis 141 
Data analysis was performed using GraphPad Prism version 6.0c (GraphPad Software, San Diego, 142 
California). Continuous variables are presented as mean±SD. Groups were compared using the one-way 143 
analysis of variance (ANOVA) with Tukey’s multiple comparisons test used to identify differences 144 
between groups. A significance level of P<0.05 was considered statistically significant. 145 
Ablation Gap Size 
RESULTS 146 
Procedural and ablation parameters 147 
All eight animals survived the protocol and no animals were excluded from analysis. There were no 148 
procedural complications. Intercaval linear ablation with a deliberate gap was achieved in all animals. 149 
Mean contact force during ablation was 16g. The dataset collected for each animal consisted of 1) acute 150 
post-ablation and chronic bipolar voltage/activation maps 2) acute post-ablation and chronic pace-capture 151 
maps 3) ablation contact force maps and 4) chronic macroscopic gap length. An example of a single 152 
complete data set is given in Figure 2. A total of 16 electroanatomic maps were included in the analysis 153 
with an average of 1380±189 points per map, equivalent to a point density of 9.7±2.8 points/cm2 (12) . 154 
Voltage mapping of non-excitable tissue 155 
Mean bipolar voltage was significantly higher at sites of pace-capture compared to sites of non-pace-156 
capture for both acute (1.64±1.44mV vs. 0.42±0.55mV, P<0.0001, Figure 3A) and chronic (1.67±1.26 vs. 157 
0.48±0.51mV, P<0.0001, Figure 3C) time points. Voltage thresholds to define non-excitable tissue were 158 
determined by ROC analysis at acute and chronic time points. Acutely, a bipolar voltage cut off <0.56mV 159 
demonstrated a sensitivity of 74% and a specificity of 81% to identify inexcitable tissue assessed by pace-160 
capture mapping (Figure 3B). Chronically, a bipolar voltage cut off <0.62mV was required to achieve 161 
similar sensitivity (78%) and specificity (80%). Voltage thresholds of <0.56mV (acute maps) and 162 
<0.62mV (chronic maps) were therefore used in the remainder of the study for analysis of voltage maps. 163 
Voltage-, pace-capture- and ablation force-based estimation of gap size 164 
A macroscopic photograph of the intercaval chronic ablation line is shown in Figure 2A. The mean 165 
macroscopic ablation gap length was 5.3±1.5mm. Taking macroscopic gap size as the gold standard, errors 166 
in gap measurements were calculated for pace capture maps, voltage maps and ablation contact force maps 167 
(Figure 4). Immediately post-ablation, both voltage and pace-capture maps over-estimated the eventual 168 
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chronic macroscopic gap size, by 9.5±3.8mm and 5.1±3.4mm, respectively. Compared to gap size 169 
estimated by acute voltage mapping, ablation contact force maps gave a significantly closer estimate of 170 
eventual chronic gap size, overestimating gap size by 1.4±2.0mm (P=0.003, Tukey’s multiple 171 
comparisons test). Chronically, voltage mapping and pace-capture mapping also both overestimated 172 
macroscopic gap size, by 11.9±3.7 and 9.8±3.5mm, respectively. Similar to the acute time point, the error 173 
in gap size estimation by ablation contact force mapping was significantly less than that for both voltage 174 
mapping and pace-capture mapping (P<0.001 and P=0.002, respectively, Tukey’s multiple comparisons 175 
test). 176 
Gap region conduction velocity 177 
To determine the relationship between gap size measured by macroscopy, voltage, pace-capture or 178 
ablation force maps and intra-gap conduction velocity, regions of the local activation time maps 179 
corresponding to the ablation gap were extracted from the acute post-ablation activation maps and mean 180 
conduction velocities in these regions were determined. Intra-gap conduction velocity was positively and 181 
significantly correlated with gap size determined by both macroscopy and ablation contact force maps 182 
(Figure 5). Consistent with the error in gap size measurement reported above for voltage and pace-capture 183 
mapping, there was no correlation between voltage or pace-capture gap size and intra-gap conduction 184 
velocity at either acute or chronic time points. Correlation co-efficient values and significance values for 185 
these relationships are summarized in Table 1. 186 
DISCUSSION 187 
The main findings of this study are 1) post ablation voltage and pace-capture mapping overestimate 188 
chronic gap size in linear ablation lesions; 2) gap size determined by analysis of contact force data most 189 
accurately estimates chronic gap size; and 3) intra-gap conduction velocity is positively correlated with 190 
both macroscopic and ablation force map-defined gap size.  191 
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It is well-recognised that acute isolation of the pulmonary veins can be achieved in the absence of 192 
irreversible tissue damage. Lesion sets can demonstrate entrance block, an accepted procedural endpoint, 193 
even in the presence of obvious visual gaps (5). Local electrophysiological changes around ablation sites 194 
including reduction in action potential duration and conduction velocity have been reported in a rabbit 195 
model (13) and cardiac MRI studies have demonstrated resolution over time of acute oedema initially seen 196 
post ablation (6). As such it is not surprising that chronic lesion formation may be insufficient to ensure 197 
complete pulmonary vein isolation. Adjunctive intraprocedural techniques have therefore been described 198 
to facilitate assessment of acute lesion sets. 199 
Pace-capture mapping 200 
Pace-capture mapping has been shown to consistently identify gaps in linear ablation sets and to predict 201 
the formation of transmural lesions (14–16). We found that pace-capture significantly overestimates 202 
macroscopic chronic gap size. Factors such as electrode-tissue contact and catheter orientation should be 203 
considered when performing pace-capture evaluation of lesion sets. Kosmidou et al demonstrated that loss 204 
of bipolar capture was 100% predictive of uniform lesion formation only in the presence of optimal tissue 205 
contact (16). Similarly, inadvertent capture of neighbouring endocardium may occur from the proximal 206 
ring of the distal electrode of the pacing catheter depending on the angle of orientation (17). In this study, 207 
a low pacing output of 3mA was chosen to minimise distant capture.  208 
Voltage Mapping 209 
Change in unipolar and bipolar voltage amplitude at ablation sites can be used to predict lesion formation 210 
and transmurality (18). A significant discrepancy was seen in our study between gap size measured acutely 211 
and chronically by voltage mapping and eventual macroscopic gap size.  212 
Several factors may influence the interpretation of voltage maps. Thresholding of voltage maps to 213 
represent ‘scar’ influences how a region is defined and may result in over or underestimation of scar. 214 
Ablation Gap Size 
Many centres accept a low voltage threshold value of 0.5mV, and a scar cut off value of 0.05mV as a 215 
matter of convention. A number of recent studies have attempted to define voltage thresholds associated 216 
with dense scar. We have previously described a mean bipolar voltage of 0.6mV and 0.3mV in acute and 217 
chronic ablation scar respectively in swine (19). Squara et al described loss of pace capture as a method 218 
of reliably identifying post ablation scar (10) and we employed this method in this study to define scar 219 
voltage thresholds. The values obtained acutely and chronically to predict inexcitable scar (0.56mV and 220 
0.62mV respectively) in this study are higher than previously described and significantly higher than the 221 
commonly-employed threshold of <0.05mV (20).  222 
Other factors to consider include activation direction, rate of activation and local conduction velocity 223 
which have all been associated with changes in voltage amplitude in atrial and ventricular myocardium 224 
(21–23). Mapping resolution, relating directly to mapping catheter electrode size and spacing, may also 225 
influence the appearance of voltage maps. Voltage may be influenced by electrode size (24) and multi-226 
electrode mapping catheters (with smaller electrodes and closer inter-electrode spacing) have 227 
demonstrated superior resolution with better delineation of low voltage zones when compared to ablation 228 
catheters (25,26). Given these findings a possible cause for the overestimation of gap size by voltage 229 
mapping in this study may be the large distal electrode (3.5mm) and wider bipolar spacing of the ablation 230 
catheter. Considering the superior ability of multi-electrode catheters, with smaller electrodes, to identify 231 
areas of preserved voltage within low voltage zones (25), new ultra high-density mapping systems may 232 
demonstrate better estimation of true gap size than seen in this study.  233 
Ablation Contact Force 234 
Gap measurements on contact force maps created from ablation tags most closely approximated eventual 235 
macroscopic gap size (27,28). The relative accuracy of these maps highlights the importance of creating 236 
a contiguous lesion set. Indeed, inter-lesion distance has been shown to be significantly higher in ablation 237 
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segments with pulmonary vein reconnection compared to segments without (4). A ‘point by point’ 238 
workflow for pulmonary vein isolation, focusing on avoiding visual gaps, maintaining catheter stability 239 
and achieving pre-defined ablation parameters may optimise the creation of contiguous, transmural lesions 240 
(29). Although results of prospective trials evaluating this technique are still awaited the present study 241 
further emphasises the importance of achieving contiguous ablation tag appearances during ablation. 242 
Clinical Relevance 243 
In current clinical practice, linear ablation is most commonly employed as an adjunct strategy in those 244 
with persistent AF or those undergoing redo procedures, for example to achieve posterior LA wall 245 
isolation. In this study we used linear ablation as a model of contiguous, point by point atrial ablation and 246 
argue that these results are relevant to any contiguous lesion set including pulmonary vein encirclement.  247 
This study directly compares gap size using voltage and pace capture maps to eventual macroscopic 248 
measurements. Overestimation of gap size by voltage mapping and pace-capture mapping may result in 249 
unnecessary additional ablation which could increase the risk of collateral tissue damage. These findings 250 
may also be of relevance when performing post ablation voltage mapping during repeat ablation 251 
procedures. Our findings in relation to conduction velocity (Figure 5)  are in line with prior work in canine 252 
models demonstrating higher rates of block in smaller (<5mm) gaps (30). Small gaps between otherwise 253 
contiguous ablation lesions may increase the risk of post ablation clinical atrial tachycardia resulting from 254 
a larger excitable gap due to lower conduction velocity within the gap (31). The comparative accuracy of 255 
contact force maps in predicting eventual gap size in this study underlines the importance for operators to 256 
focus on achieving contiguous, effective ablation during the index procedure. 257 
LIMITATIONS 258 
The results presented in this study describe methods of ablation line gap size estimation in a porcine 259 
model. While the porcine right atrium closely resembles the human left atrium in terms of tissue thickness, 260 
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we acknowledge the inherent limitation posed by extrapolating findings from animal models to humans. 261 
Ablation was performed in this study as a slow drag lesion rather than point by point ablation. Titrated RF 262 
delivery using a point by point work flow may represent a more effective method of linear ablation, 263 
however to the best of our knowledge there are no comparative studies demonstrating histological 264 
differences between continuous and point-by-point ablation. Furthermore, in a previous study using the 265 
same ablation model we demonstrated effective lesion formation throughout the ablation line (11). Bipolar 266 
pacing may have resulted in a wide area of tissue capture resulting in overestimation of gap size (see above 267 
in ‘Discussion’). Whether unipolar pacing would have resulted in more accurate estimation of gap size 268 
cannot be determined from this data. 269 
CONCLUSION 270 
Voltage and pace-capture mapping along ablation lines may be used as intra-procedural tools to identify 271 
gaps in acute lesion sets. Both these techniques over estimate eventual gap size as defined by chronic 272 
macroscopic assessment. Contact force maps created from ablation tags demonstrated the greatest 273 
accuracy in predicting eventual gap size. Further work is needed to evaluate the integrity of lesion sets 274 
created using a point by point work flow focused on contiguous lesions meeting pre-defined ablation 275 
parameters.  276 
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APPENDICES 391 
Table 1. Correlations between gap size and conduction velocity. 392 
 393 
Gap measurement method Correlation with intra-gap conduction velocity 
R2 P 
Macroscopy 0.5954 0.0249 * 
Force map (acute) 0.5615 0.0323 * 
Pace-capture (acute) 0.2852 0.1728 
Voltage (acute) 0.0269 0.6982 
Pace-capture (chronic) 0.0504 0.5928 
Voltage (chronic) 0.0897 0.4712 
 * indicates statistical significance (P<0.05). 394 
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Figure 1. Gap Region Definition. 
A. Map demonstrating the linear ablation lesion. Red indicates the area where a contact force of > 5g was achieved. B. Activation map from which 
a region of interest corresponding to the gap in the ablation line was extracted to allow calculation of conduction velocity within the gap. 
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Figure 2. Study Data. 
A. Macroscopic gap assessment. Gap in ablation line (white and black stars) is indicated by a white arrow. B. Acute post ablation (<30mins) 
voltage and pace-capture map. Lower voltage threshold set at 0.56mV. Sites of pace-capture indicated by yellow tags. C. Chronic post ablation (2 
months) voltage and pace-capture map. Lower voltage threshold set at 0.62mV. Sites of pace-capture indicated by yellow tags, sites of no pace-
capture indicated by brown tags. D. Ablation tag/contact force maps. Contact force data from the Carto 3 system was interpolated to within 5mm 
of each ablation tag and thresholded at a force of 5g. 
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Figure 3. Bipolar Voltage Characteristics at excitable and non-excitable sites. 
A. Mean bipolar voltages at sites of acute pace-capture are higher than at sites of non-capture. B. ROC analysis for acute bipolar voltage/pace-
capture. C. Mean bipolar voltage at sites of chronic pace-capture are higher than at sites of non-capture. D. ROC analysis of chronic bipolar 
voltage/pace-capture.   
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Figure 4.  Representative Figure. Gap Size Errors.  
Intraprocedural gap measurement errors. Gap size as determined by force maps and pace-capture and voltage maps at acute and chronic time points 
were compared to eventual chronic macroscopic gap size.  
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Figure 5. Relationship Between Gap Size and Conduction Velocity. 
A. Conduction velocity was positively correlated with gap size determined by macroscopic assessment. B. Conduction velocity was positively 
correlated with gap size determined by analysis of ablation contact force maps at a low force cut off threshold of >5g.  
 
 
